INSTILLATION SITE COMPLICATION

INSTILLATION SITE COMPLICATION was reported 21 times

INSTILLATION SITE COMPLICATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LATANOPROST OPHTHALMIC SOLUTION 0.005% 1 0.0016
1 CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 1 0.0015
2 RESLIZUMAB 1 0.0015
3 CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN 1 0.0004
4 CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN 1 0.0004
5 LIFITEGRAST 4 0.0002
6 CLINDAMYCIN PHOSPHATE 1 0.0002
7 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 1 0.0002
8 DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE 1 0.0001
9 ALTEPLASE 1 0.0001
10 TESTOSTERONE 1 0.0000
11 BIMATOPROST 1 0.0000
12 BEVACIZUMAB 3 0.0000
13 MAGNESIUM OXIDE 1 0.0000
14 0XYGEN 1 0.0000
15 OXYGEN 1 0.0000
16 CONJUGATED ESTROGENS 1 0.0000
17 ESTROGENS, CONJUGATED 1 0.0000
18 FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE 1 0.0000
19 EPINEPHRINE 1 0.0000
20 TADALAFIL 1 0.0000
21 CYCLOSPORINE 1 0.0000
22 AMBRISENTAN 1 0.0000
23 TREPROSTINIL 1 0.0000
24 CELECOXIB 1 0.0000
25 TIOTROPIUM BROMIDE 1 0.0000
26 SPIRONOLACTONE 1 0.0000
27 NAPROXEN SODIUM 1 0.0000
28 LEVOTHYROXINE SODIUM 2 0.0000
29 ALPRAZOLAM 1 0.0000
30 ALBUTEROL SULFATE 1 0.0000
31 OMEPRAZOLE MAGNESIUM 1 0.0000
32 PREDNISONE 1 0.0000